Blauel ER, Laetsch TW. “The promise of TRK inhibitors in pediatric cancers with NTRK fusions.” Cancer Genet. 2022;262-263:71-79. [PMID: 35108663]
Modi, A., Blauel, E., Diskin, S.J. (2024). Genetic Predisposition. In: Asgharzadeh, S., Westermann, F. (eds) Neuroblastoma. Pediatric Oncology. Springer, Cham.
Emily Blauel-Bocko et al., Vincristine (VCR) pharmacokinetics (PK) in infants dosed using a body surface area (BSA) banded dosing table and in older children dosed based on BSA: A pediatric early phase clinical trial network study (PEPN22P1). JCO 42, 10015-10015(2024).